National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "6 Categories of Scientific Evidence--Information About Related Substances." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
205
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety
  • If production of a hazardous phytochemical in a botanical appears to be particularly sensitive to environmental and growth conditions, then it may be appropriate to consider its use in dietary supplements as a risk unless quality control or other actions are implemented to assure that toxic levels of compounds are not reached in raw materials or finished products.

  • Preparation affects toxicity. Materials that are traditionally consumed in cooked form may not have the same safety profile as in uncooked form, compounds that are concentrated or otherwise altered by the method of preparation will present a hazard that is of greater concern than for unprocessed material, and knowledge about the safety of one plant preparation should not be applied prima facie to different preparations of the same plant.

  • Particular concern should arise when nontraditional or excessive levels of plant parts are consumed. There may be a tendency to consume more of the plant material in an encapsulated form than if it were used in its “native” form.

  • Extraction of plant material with alcohol or aqueous alcohol, in which low-molecular-weight compounds are generally very soluble, will likely concentrate toxic components several fold. Thus, for botanicals containing toxic compounds, a shift from aqueous to alcoholic extracts should be a cause for concern unless there is credible evidence to mitigate this concern.

OTHER APPROACHES FOR CONSIDERING STRUCTURAL SIMILARITY TO KNOWN CLASSES OF TOXIC COMPOUNDS

GUIDING PRINCIPLE: Compounds that are similar in structure may have similar biological functions. If the chemical structure of a dietary supplement is known, but additional insight into the biological activity is needed, then it is scientifically appropriate to consider the information about the biological activity of structurally related substances and the general knowledge about adverse effects associated with toxicophores.

The physical–chemical properties and biological effects of a substance are derived from its chemical structure. If the chemical structure of a dietary supplement is known, but additional insight into the biological activity is needed, then it is scientifically appropriate to consider the information about the biological activity of structurally related substances. It is assumed that the biological effects of chemicals, including toxic effects, are implicit

Page
205
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)